Natural Capsules Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Natural Capsules Share Price

158.56-0.85 (-0.54%)

Live
As On: 24 Jun, 2026, 09:45 AM IST
As On: 23 Jun, 2026, 03:40 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	163.90
High	163.90
Low	158.50
Prev Close	159.41
Volume	2,831
VWAP(₹)	159.25

Key Metrics

PE Ratio(x)	-7.12
EPS - TTM(₹)	-22.27
MCap(₹ Cr.)	165.57
MCap Rank	107
PB Ratio(x)	0.71
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	296.00
52W Low(₹)	136.36
MCap/Sales	0.80
Beta(1 Month)	-
BV/Share(₹)	226.00

Natural Capsule share price insights

Passing Profits to Shareholders
Company has consistently declining ROE in last 5 years. Majority of profits last year were disbursed as dividends to shareholders. (Source: Consolidated Financials)
PAT: Troublesome Times
Company has posted a loss of Rs 3.45 cr for the 4th consecutive quarter. (Source: Consolidated Financials)
Quarterly Topline Performance
Company witnessed QoQ revenue growth of 55.05%, which is highest in the last 3 years. (Source: Consolidated Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 11.2% outperformed its 3 year CAGR of 2.96%. (Source: Consolidated Financials)
Natural Capsule Share Price Update
Natural Capsules Ltd. share price moved down by -0.54% from its previous close of Rs 159.41. Natural Capsules Ltd. stock last traded price is 158.56
Share Price Value
Today/Current/Last 158.56158.25
Previous Day 159.41158.10

Found Insights useful?

Natural Capsule Share Price Returns

1 Day	-0.54%
1 Month	4.8%
3 Months	10.39%
1 Year	-28.51%
3 Years	N.A.
5 Years	N.A.

Natural Capsule Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Natural Capsule Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	38.19	45.96	45.56	45.27	43.94
Total Income Growth (%)	-16.91	0.88	0.63	3.04	6.31
Total Expenses	44.43	50.98	49.10	42.74	41.89
Total Expenses Growth (%)	-12.84	3.83	14.86	2.03	7.23
EBIT	-6.24	-5.01	-3.53	2.53	2.04
EBIT Growth (%)	-	-	-239.70	23.82	-9.67
Profit after Tax (PAT)	-7.12	-6.99	-5.58	0.52	0.11
PAT Growth (%)	-	-	-1,171.73	392.62	-
EBIT Margin (%)	-16.33	-10.90	-7.76	5.59	4.65
Net Profit Margin (%)	-18.63	-15.21	-12.25	1.15	0.24
Basic EPS (₹)	-6.88	-6.76	-5.40	0.13	0.10

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	36.25	46.31	45.93	45.91	44.56
Total Income Growth (%)	-21.71	0.82	0.05	3.02	6.61
Total Expenses	34.34	41.16	41.10	41.25	40.96
Total Expenses Growth (%)	-16.57	0.15	-0.38	0.70	7.12
EBIT	1.91	5.15	4.84	4.66	3.60
EBIT Growth (%)	-62.86	6.50	3.83	29.40	1.14
Profit after Tax (PAT)	0.36	2.81	2.52	2.63	1.70
PAT Growth (%)	-87.11	11.39	-3.94	54.22	84.69
EBIT Margin (%)	5.28	11.12	10.53	10.14	8.08
Net Profit Margin (%)	1.00	6.07	5.49	5.72	3.82
Basic EPS (₹)	0.35	2.72	2.44	2.17	1.65

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	169.91	157.36	172.94	136.08	80.24
Total Revenue Growth (%)	7.98	-9.01	27.09	69.58	28.37
Total Expenses	167.12	149.30	147.95	116.69	73.26
Total Expenses Growth (%)	11.93	0.92	26.78	59.28	19.84
Profit after Tax (PAT)	0.62	5.55	18.45	13.91	6.91
PAT Growth (%)	-88.88	-69.89	32.57	101.29	706.05
Operating Profit Margin (%)	5.38	8.48	16.47	15.80	9.24
Net Profit Margin (%)	0.36	3.57	10.70	10.30	8.69
Basic EPS (₹)	0.23	6.25	19.82	19.56	10.99

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	172.17	156.95	173.93	136.00	80.24
Total Revenue Growth (%)	9.70	-9.76	27.89	69.49	28.37
Total Expenses	162.88	146.56	148.19	116.57	73.23
Total Expenses Growth (%)	11.14	-1.10	27.12	59.19	19.77
Profit after Tax (PAT)	6.71	7.81	19.20	13.95	6.95
PAT Growth (%)	-14.02	-59.35	37.58	100.86	710.11
Operating Profit Margin (%)	9.05	9.97	16.94	15.83	9.28
Net Profit Margin (%)	3.99	5.07	11.10	10.33	8.73
Basic EPS (₹)	6.43	8.67	20.63	19.62	11.04

All figures in Rs Cr, unless mentioned otherwise

Insights

PAT: Troublesome Times
Company has posted a loss of Rs 3.45 cr for the 4th consecutive quarter. (Source: Consolidated Financials)
Quarterly Topline Performance
Company witnessed QoQ revenue growth of 55.05%, which is highest in the last 3 years. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	419.35	376.53	288.76	164.28	97.04
Total Assets Growth (%)	11.37	30.39	75.78	69.29	29.93
Total Liabilities	162.19	147.72	140.52	81.30	34.94
Total Liabilities Growth (%)	9.80	5.13	72.84	132.65	83.30
Total Equity	257.16	228.80	148.25	82.98	62.10
Total Equity Growth (%)	12.39	54.34	78.65	33.63	11.64
Current Ratio (x)	1.30	1.62	1.52	1.63	1.24
Total Debt to Equity (x)	0.45	0.53	0.78	0.61	0.16
Contingent Liabilities	85.13	114.11	109.54	147.83	16.89

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	268.08	231.26	210.40	143.49	96.66
Total Assets Growth (%)	15.92	9.91	46.63	48.45	29.43
Total Liabilities	101.76	99.40	86.34	60.44	34.53
Total Liabilities Growth (%)	2.37	15.13	42.85	75.04	81.16
Total Equity	166.32	131.86	124.05	83.05	62.13
Total Equity Growth (%)	26.13	6.30	49.37	33.67	11.70
Current Ratio (x)	1.28	1.31	1.24	1.72	1.18
Total Debt to Equity (x)	0.33	0.47	0.40	0.37	0.15
Contingent Liabilities	76.08	76.73	55.15	74.36	16.89

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	26.75	-8.35	17.22	1.16	12.60
Net Cash used in Investing Activities	-44.48	-72.59	-104.63	-45.88	-15.58
Net Cash flow from Financing Activities	16.17	81.72	87.49	46.02	2.75
Net Cash Flow	-1.57	0.78	0.08	1.30	-0.23
Closing Cash & Cash Equivalent	0.69	2.25	1.48	1.40	0.10
Closing Cash & Cash Equivalent Growth (%)	-69.45	52.59	5.66	1,332.62	-70.42
Total Debt/ CFO (x)	3.88	-13.05	5.61	43.57	0.76

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	18.03	5.40	20.11	5.09	5.55
Net Cash used in Investing Activities	-34.37	-10.84	-55.42	-30.42	-8.54
Net Cash flow from Financing Activities	14.81	7.23	34.44	26.51	2.75
Net Cash Flow	-1.53	1.79	-0.87	1.18	-0.24
Closing Cash & Cash Equivalent	0.67	2.19	0.40	1.28	0.09
Closing Cash & Cash Equivalent Growth (%)	-69.56	444.46	-68.46	1,272.39	-71.63
Total Debt/ CFO (x)	3.05	11.48	2.44	6.10	1.74

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 10.77 cr for investing activities which is an YoY decrease of 75.8%. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	0.26	2.72	14.96	16.76	11.13
Return on Capital Employed (%)	2.85	4.39	12.80	18.11	11.63
Return on Assets (%)	0.14	1.47	6.38	8.46	7.12
Interest Coverage Ratio (x)	2.89	4.26	10.45	13.46	19.83
Asset Turnover Ratio (x)	0.43	0.47	0.92	1.12	81.93
Price to Earnings (x)	312.50	51.55	19.76	23.31	9.70
Price to Book (x)	0.82	1.40	2.96	3.91	1.08
EV/EBITDA (x)	17.19	18.57	13.46	14.01	6.39
EBITDA Margin (%)	10.76	14.05	20.65	19.53	14.65

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	4.03	5.91	15.47	16.80	11.18
Return on Capital Employed (%)	7.89	9.48	19.50	21.73	11.68
Return on Assets (%)	2.50	3.37	9.12	9.72	7.18
Interest Coverage Ratio (x)	3.98	4.83	10.27	13.48	19.93
Asset Turnover Ratio (x)	0.67	0.70	0.98	1.12	82.26
Price to Earnings (x)	28.41	36.63	19.01	23.26	9.65
Price to Book (x)	1.15	2.16	2.94	3.90	1.08
EV/EBITDA (x)	10.32	14.13	11.27	13.33	6.50
EBITDA Margin (%)	14.01	15.54	21.11	19.56	14.70

Insights

Passing Profits to Shareholders
Company has consistently declining ROE in last 5 years. Majority of profits last year were disbursed as dividends to shareholders. (Source: Consolidated Financials)

Found Financials useful?

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Natural Capsule	-7.12	0.70	-7.70	-5.82	-4.02	2.96	-9.06	-13.17	-23.84	1.03	0.52	10.47
Aarey Drugs	58.24	1.75	2.63	6.84	1.33	4.25	2.20	0.84	1.39	1.81	0.33	4.93
Ambalal Sarabhai	14.07	1.58	11.24	12.59	6.33	5.90	11.36	8.59	2.32	1.27	0.33	3.85
Lyka Labs	-23.81	2.63	-10.85	-7.00	-5.74	10.88	-6.57	-8.12	-2.81	1.17	0.52	9.22
Brooks Labs	9.03	1.81	20.04	5.25	16.59	10.96	7.74	6.77	8.35	1.72	0.06	0.78
Add More

Annual Ratios (%)

Choose from Peers

Nectar Lifesc
Krebs Biochem
Alpa Labs
Bal Pharma
Par Drugs & Chemical

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 53,01,248 51.04 % -0.21
Pledge 0 0.00 % 0.00
FII 0 0.00 % 0.00
DII 0 0.00 % 0.00
MF 0 0.00 % 0.00
Others 50,84,906 48.96 % 0.21
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 51.04 51.26 51.26 51.26
Pledge 0.00 0.00 0.00 0.00
FII 0.00 0.00 0.00 0.00
DII 0.00 0.00 0.00 0.00
Mutual Funds 0.00 0.00 0.00 0.00
Others 48.96 48.74 48.74 48.74

Mutual Funds Ownership

No Data Available

Natural Capsule Top Searches

Corporate Actions

Recent
Board Meeting
Audited Results
May 20, 2026
General Meeting
-
Feb 24, 2026
Board Meeting
Quarterly Results
Feb 04, 2026

Announced on	Meeting on
May 20, 2026	May 27, 2026
Audited Results
Feb 04, 2026	Feb 13, 2026
Quarterly Results
Nov 03, 2025	Nov 13, 2025
Quarterly Results
Jul 28, 2025	Aug 04, 2025
Quarterly Results
May 22, 2025	May 29, 2025
Audited Results

Dividends
Announced on Ex-Date Dividend%
May 26, 2023 Jul 20, 2023 10%
May 09, 2022 Sep 09, 2022 10%
May 31, 2021 Jul 06, 2021 10%
Jun 05, 2020 Aug 12, 2020 6%
May 30, 2019 Aug 13, 2019 10%
Bonus
No Data Available
Splits
No Data Available
Rights
Announced on Ex-Date
Aug 07, 2021 Nov 11, 2021
Rights ratio: 1 share for every 2 held at a price of Rs 100.0
Aug 07, 2021 -
Rights ratio: 1 share for every 2 held at a price of Rs 90.0
AGM/EGM Meetings
Announced on Meeting on
Feb 24, 2026 Mar 29, 2026
-
Jul 14, 2025 Aug 04, 2025
-
Jul 31, 2024 Aug 23, 2024
-
Jul 02, 2024 Jul 26, 2024
-
Jul 04, 2023 Jul 28, 2023
Rs.1.0000 per share(10%)Final Dividend & A.G.M.

About Natural Capsule

Natural Capsules Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 165.57 Crore) operating in Pharmaceuticals sector.

Natural Capsules Ltd. key Products/Revenue Segments include Empty Hard Gelatine (EHG) Capsules and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 59.22 Crore, up 55.05 % from last quarter Total Income of Rs 38.19 Crore and up 30.80 % from last year same quarter Total Income of Rs 45.27 Crore. Company has reported net profit after tax of Rs -4.98 Crore in latest quarter.

The company’s top management includes Mr.Tekkar Yashwanth Prabhu, Mr.Sunil Laxminarayana Mundra, Mr.Laxminarayan Moondra, Mr.Satyanarayana Mundra, Mr.Pramod Kasat, Mr.S G Belapure, Mrs.Jyoti Mundra, Mr.Sushil Kumar Mundra, Mr.R K Prasad, Ms.Pranjal Deshmukh. Company has P Chandrasekar LLP as its auditors. As on 31-03-2026, the company has a total of 1.04 Crore shares outstanding.

Natural Capsule Share Price Today is Rs. 158.56. On previous day, the Natural Capsule Share Price (NSE) closed at Rs. 156.68, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 51.04% of the stake in Natural Capsule shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Natural Capsule stocks was 0.0% as compared to 0.0% in Dec 2025 with decrease of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in Natural Capsule shares 0.0% was held by mutual funds. The rest including public held is 48.96%. Natural Capsule stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Natural Capsule Dividend: Ever since 1993, Natural Capsule dividends has been paid out around 19 times. As on 24 Jun, 2026, 09:45 AM IST, The overall dividend yield for Natural Capsule stands at 0.0%. The last dividend paid was on July 20, 2023 (Rs. 1.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -22.27.

Natural Capsule Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 59.22 Cr. of sales and 55.05% of quarterly net profit, there have been multiple ups and downs in the Natural Capsule stock prices in the past few weeks. For example, Natural Capsule stock price on 16th of June 2026 was around Rs. 151.29. Natural Capsule share price now stands at an average of Rs. 158.56. Judging by last week's performance, stock is in up trend.

Natural Capsule has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Natural Capsule share.

Historical Prices and Performance:
Natural Capsule, incorporated in 1993 is a Small Cap company (with a market cap of Rs. 165.57) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Natural Capsule stock was -7.7%, 0.26%, 2.72%, 14.96% and 16.76% respectively.
The Natural Capsule share gave a 3 year return of 3.88% as compared to Nifty 50 which gave a return of 34.66%.
Natural Capsule announced 10.0% final dividend on July 20, 2023.

Key Metrics:
PE Ratio of Natural Capsule is -7.03
Prices/Sales Ratio of Natural Capsule is 0.8
Price/Book Ratio of Natural Capsule is 0.69

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Natural Capsule, major competitors and peers include Aarey Drugs, Ambalal Sarabhai, Lyka Labs and Nectar Lifesc. As of Dec 2025, the dividend yield of Natural Capsule stands at 0.0% while Aarey Drugs, Ambalal Sarabhai, Lyka Labs and Nectar Lifesc stand at 0.0%, 0.0%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at -7.03 and 0.69 respectively.

Leadership of Natural Capsule :
Pranjal Deshmukh is Co. Secretary & Compl. Officer
R K Prasad is Chief Financial Officer
Tekkar Yashwanth Prabhu is Chairman & Ind.Director
Sunil Laxminarayana Mundra is Managing Director
Laxminarayan Moondra is Whole Time Director
Satyanarayana Mundra is Whole Time Director
S G Belapure is Independent Director
Pramod Kasat is Independent Director
Sushil Kumar Mundra is Director
Jyoti Mundra is Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

-

Address

Trident Towers, 4th Floor,No. 23, 100 Feet Road,Bengaluru, Karnataka - 560011

Contact

company.sec@naturalcapsules.com

http://www.naturalcapsules.com

Executive Leadership

TY

Tekkar Yashwanth Prabhu

Chairman & Ind.Director

SL

Sunil Laxminarayana Mundra

Managing Director

LM

Laxminarayan Moondra

Whole Time Director

SM

Satyanarayana Mundra

Whole Time Director

Show More

Auditors

P Chandrasekar LLP

FAQs about Natural Capsule share

1. What's the Natural Capsule share price today?
Natural Capsule share price is Rs 158.56 as on 24 Jun, 2026, 09:45 AM IST. Natural Capsule share price is down by 0.54% based on previous share price of Rs 156.68. Natural Capsule share price trend:
- Last 3 Years: Natural Capsule Share price moved remain unchanged by N.A.
2. What are the returns for Natural Capsule share?
Return Performance of Natural Capsule Shares:
- 1 Week: Natural Capsule share price moved up by 4.49%
3. What is the market cap of Natural Capsule?
Within the Pharmaceuticals sector, Natural Capsule stock has a market cap rank of 107. Natural Capsule has a market cap of Rs 165.57 Cr.
4. What has been highest price of Natural Capsule share in last 52 weeks?
52 Week high of Natural Capsule share is Rs 296.00 while 52 week low is Rs 136.36
5. What is the PE & PB ratio of Natural Capsule?
The PE ratio of Natural Capsule stands at -7.16, while the PB ratio is 0.71.

Top Gainers

As on 09:45 AM | 24 Jun 2026

1,255.50

124.35 (11.00%)

2,776.00

95.00 (3.55%)

2,575.50

84.60 (3.40%)

JSW Infrastructure

325.60

10.66 (3.39%)

10,182.00

319.50 (3.24%)

Top Losers

As on 09:45 AM | 24 Jun 2026

93.84

-4.83 (-4.90%)

5,147.00

-257.00 (-4.76%)

509.50

-24.25 (-4.55%)

34,505.00

-1585.00 (-4.40%)

Triveni Turbine

686.75

-30.90 (-4.31%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.